Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

Northwest Biotherapeutics (NWBO) Amortization of Deferred Charges (2016 - 2025)

Northwest Biotherapeutics' Amortization of Deferred Charges history spans 15 years, with the latest figure at $614000.0 for Q4 2025.

  • Quarterly results put Amortization of Deferred Charges at $614000.0 for Q4 2025, down 28.44% from a year ago — trailing twelve months through Dec 2025 was $1.9 million (down 23.79% YoY), and the annual figure for FY2025 was $1.9 million, down 23.79%.
  • Amortization of Deferred Charges for Q4 2025 was $614000.0 at Northwest Biotherapeutics, up from $414000.0 in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $1.1 million in Q1 2021 to a low of $231000.0 in Q2 2021.
  • The 5-year median for Amortization of Deferred Charges is $578000.0 (2021), against an average of $590350.0.
  • Peak annual rise in Amortization of Deferred Charges hit 1307.5% in 2021, while the deepest fall reached 80.09% in 2021.
  • Year by year, Amortization of Deferred Charges stood at $580000.0 in 2021, then grew by 13.79% to $660000.0 in 2022, then plummeted by 44.55% to $366000.0 in 2023, then surged by 134.43% to $858000.0 in 2024, then dropped by 28.44% to $614000.0 in 2025.
  • According to Business Quant data, Amortization of Deferred Charges over the past three periods came in at $614000.0, $414000.0, and $525000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.